Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk Samples

In this study, we propose a simple, cost-effective, and sensitive high-performance liquid chromatography with fluorescence detection (HPLC-FLD) for the simultaneous determination of seven bisphenols (bisphenol F (BPF), bisphenol E (BPE), bisphenol B (BPB), BADGE (bisphenol A diglycidyl ether), BADGE...

Full description

Bibliographic Details
Main Authors: Tomasz Tuzimski, Szymon Szubartowski
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/16/4930
_version_ 1797522698429005824
author Tomasz Tuzimski
Szymon Szubartowski
author_facet Tomasz Tuzimski
Szymon Szubartowski
author_sort Tomasz Tuzimski
collection DOAJ
description In this study, we propose a simple, cost-effective, and sensitive high-performance liquid chromatography with fluorescence detection (HPLC-FLD) for the simultaneous determination of seven bisphenols (bisphenol F (BPF), bisphenol E (BPE), bisphenol B (BPB), BADGE (bisphenol A diglycidyl ether), BADGE∙2H<sub>2</sub>O, BADGE∙H<sub>2</sub>O, BADGE∙2HCl) in human breast milk samples. The dispersive solid phase extraction (d-SPE) coupled with solid phase extraction (SPE) procedure performed well for the majority of the analytes with recoveries in the range 57–88% and relative standard deviations (RSD%) of less than 9.4%. During the d-SPE stage, no significant matrix effect was observed thanks to the application of different pairs of salts such as zirconium-dioxide-based sorbents (Z-Sep or Z-Sep +) and primary secondary amine (PSA) or QuEChERS Enhanced Matrix Removal-Lipid (EMR-Lipid) and PSA. The method limits of quantification (mLOQs) for all investigated analytes were set at satisfactory low values in the range 171.89–235.11 ng mL<sup>−1</sup>. Analyte concentrations were determined as the average value from human breast milk matrix samples. The results show that the d-SPE/SPE procedure, especially with the application of EMR-Lipid and PSA, could be used for further bisphenol analyses in human breast milk samples.
first_indexed 2024-03-10T08:33:07Z
format Article
id doaj.art-5265e150d97b4af5ba28762671d082ef
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T08:33:07Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-5265e150d97b4af5ba28762671d082ef2023-11-22T08:54:05ZengMDPI AGMolecules1420-30492021-08-012616493010.3390/molecules26164930Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk SamplesTomasz Tuzimski0Szymon Szubartowski1Department of Physical Chemistry, Medical University of Lublin, Chodźki 4a, 20-093 Lublin, PolandDepartment of Physical Chemistry, Medical University of Lublin, Chodźki 4a, 20-093 Lublin, PolandIn this study, we propose a simple, cost-effective, and sensitive high-performance liquid chromatography with fluorescence detection (HPLC-FLD) for the simultaneous determination of seven bisphenols (bisphenol F (BPF), bisphenol E (BPE), bisphenol B (BPB), BADGE (bisphenol A diglycidyl ether), BADGE∙2H<sub>2</sub>O, BADGE∙H<sub>2</sub>O, BADGE∙2HCl) in human breast milk samples. The dispersive solid phase extraction (d-SPE) coupled with solid phase extraction (SPE) procedure performed well for the majority of the analytes with recoveries in the range 57–88% and relative standard deviations (RSD%) of less than 9.4%. During the d-SPE stage, no significant matrix effect was observed thanks to the application of different pairs of salts such as zirconium-dioxide-based sorbents (Z-Sep or Z-Sep +) and primary secondary amine (PSA) or QuEChERS Enhanced Matrix Removal-Lipid (EMR-Lipid) and PSA. The method limits of quantification (mLOQs) for all investigated analytes were set at satisfactory low values in the range 171.89–235.11 ng mL<sup>−1</sup>. Analyte concentrations were determined as the average value from human breast milk matrix samples. The results show that the d-SPE/SPE procedure, especially with the application of EMR-Lipid and PSA, could be used for further bisphenol analyses in human breast milk samples.https://www.mdpi.com/1420-3049/26/16/4930bisphenolshuman breast milk sampleshigh-performance liquid chromatography (HPLC)fluorescence detector (FLD)dispersive solid phase extraction (d-SPE)/solid phase extraction (SPE)BADGE (bisphenol A diglycidyl ether) and its derivatives
spellingShingle Tomasz Tuzimski
Szymon Szubartowski
Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk Samples
Molecules
bisphenols
human breast milk samples
high-performance liquid chromatography (HPLC)
fluorescence detector (FLD)
dispersive solid phase extraction (d-SPE)/solid phase extraction (SPE)
BADGE (bisphenol A diglycidyl ether) and its derivatives
title Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk Samples
title_full Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk Samples
title_fullStr Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk Samples
title_full_unstemmed Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk Samples
title_short Application of d-SPE before SPE and HPLC-FLD to Analyze Bisphenols in Human Breast Milk Samples
title_sort application of d spe before spe and hplc fld to analyze bisphenols in human breast milk samples
topic bisphenols
human breast milk samples
high-performance liquid chromatography (HPLC)
fluorescence detector (FLD)
dispersive solid phase extraction (d-SPE)/solid phase extraction (SPE)
BADGE (bisphenol A diglycidyl ether) and its derivatives
url https://www.mdpi.com/1420-3049/26/16/4930
work_keys_str_mv AT tomasztuzimski applicationofdspebeforespeandhplcfldtoanalyzebisphenolsinhumanbreastmilksamples
AT szymonszubartowski applicationofdspebeforespeandhplcfldtoanalyzebisphenolsinhumanbreastmilksamples